Our analysis revealed significant activation of JAK/STAT3, KRAS signaling, epithelial-EMT, and IL2/STAT5 signaling in the Mutp53 group, highlighting the broad impact of the p.R248Q mutation in PCa. The gene discussed is IL2; the disease is posterior cortical atrophy.